Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517-23. doi: 10.1016/j.eimc.2016.02.025. Epub 2016 Apr 5.

Abstract

Opportunistic infections continue to be a cause of morbidity and mortality in HIV-infected patients. They often arise because of severe immunosuppression resulting from poor adherence to antiretroviral therapy, failure of antiretroviral therapy, or unawareness of HIV infection by patients whose first clinical manifestation of AIDS is an opportunistic infection. The present article is an executive summary of the document that updates the previous recommendations on the prevention and treatment of opportunistic infections in HIV-infected patients, namely, infections by parasites, fungi, viruses, mycobacteria, and bacteria, as well as imported infections. The article also addresses immune reconstitution inflammatory syndrome. This document is intended for all professionals who work in clinical practice in the field of HIV infection.

Keywords: AIDS; HIV infection; Infecciones oportunistas; Infección por VIH; Opportunistic infections; Sida.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / prevention & control
  • Bacterial Infections / drug therapy
  • Bacterial Infections / prevention & control
  • Coinfection / drug therapy
  • Coinfection / prevention & control
  • HIV Infections / complications*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome / diagnosis
  • Immune Reconstitution Inflammatory Syndrome / drug therapy
  • Immune Reconstitution Inflammatory Syndrome / prevention & control
  • Mycoses / drug therapy
  • Mycoses / prevention & control
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / prevention & control*
  • Parasitic Diseases / drug therapy
  • Parasitic Diseases / prevention & control
  • Virus Diseases / drug therapy
  • Virus Diseases / prevention & control